DNA

Collette Health Transforms Virtual Care Delivery with Vonage

Technology Partnership Improves Patient Outcomes in Healthcare Through Advanced Video API and Virtual Nursing Solutions HOLMDEL, N.J., Oct. 20, 2025…

3 months ago

Palisade Bio Announces First Patients Dosed in Phase 1b Study of Oral First-In-Class PDE4 Inhibitor Prodrug, PALI-2108, for the Treatment of Fibrostenotic Crohn’s Disease (FSCD)

First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapies Topline safety, PK, and…

3 months ago

Oscar Unveils New Choices and AI Tools Shaping the Future of Individual Healthcare for More Americans and Businesses

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (NYSE: OSCR), a leading healthcare technology company, is introducing a suite of easy-to-use health plans…

3 months ago

Precede Biosciences Presents New ESMO 2025 Data Demonstrating Its Liquid Biopsy Platform’s Ability to Resolve Target Expression and Molecular Subtypes in Small Cell Lung Cancer

Small cell lung cancer (SCLC) accounts for 15% of all lung cancers and remains an aggressive disease with median survival…

3 months ago

Olema Oncology Announces New Data from the Phase 1b/2 Trial of Palazestrant Plus Ribociclib in ER+/HER2- Metastatic Breast Cancer at ESMO 2025

Palazestrant in combination with ribociclib demonstrated encouraging activity across all dose cohorts and subgroups Median PFS was 15.5 months in…

3 months ago

General Oncology Announces Promising Preliminary Phase 1 Results from SHARON Trial Presented at ESMO 2025

Novel regimen GO-4, combining melphalan, BCNU, hydroxocobalamin, ascorbic acid, and autologous stem cells shows manageable adverse reactions and a strong signal of efficacy in patients with BRCA-related…

3 months ago

A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan

ROLLE, Switzerland and TOKYO, Oct. 16, 2025 /PRNewswire/ -- A.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS (Nasdaq: SOPH),…

3 months ago

Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing

New device has the potential to help empower decentralized PCR testing in nearly 30,000 primary health centers across India, advancing…

3 months ago

Meet Caravel: Pioneering a New Era of Biotechnology with the First Unified Platform for Protein Discovery and Delivery

Backed by a $7.8M award from the National Science Foundation, Caravel unlocksbreakthroughs across animal health, biochemical manufacturing, and beyond. PORTLAND,…

3 months ago

PAJUNK® Expands U.S. Headquarters in Alpharetta, Georgia

Facility Growth Adds 30,000 Square Feet to Strengthen Warehouse, Cleanroom Production, and Office Capabilities ALPHARETTA, Ga., Oct. 16, 2025 /PRNewswire/…

3 months ago